Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Jul 17;15(7):1564.
doi: 10.3390/v15071564.

SARS-CoV-2 Infection and Preeclampsia-How an Infection Can Help Us to Know More about an Obstetric Condition

Otilia González-Vanegas  1 , Oscar Martinez-Perez  2
Affiliations
Review

SARS-CoV-2 Infection and Preeclampsia-How an Infection Can Help Us to Know More about an Obstetric Condition

Otilia González-Vanegas et al. Viruses. .

Abstract

Pregnant women with SARS-CoV-2 infection have a significantly higher risk of maternal death, ICU admission, preterm delivery, and stillbirth compared to those without infection. Additionally, the risk of preeclampsia (PE) increases in pregnant women infected with SARS-CoV-2, particularly in severe cases. The association between COVID-19 and PE is likely attributed to various mechanisms, including direct effects of the virus on trophoblast function and the arterial wall, exaggerated inflammatory response in pregnant women, local inflammation leading to placental ischemia, SARS-CoV-2-related myocardial injury, cytokine storm, and thrombotic microangiopathy. This paper aims to explore the similarities between PE and SARS-CoV-2 infection, considering COVID-19 as a valuable study model. By examining these parallels, we can enhance our knowledge and comprehension of PE. We wish to emphasize the potential for COVID-19-induced myocardial injury in pregnant women and its connection to the increased maternal mortality rate.

Keywords: COVID-19; SARS-CoV-2; inflammation; myocardial injury; preeclampsia; pregnancy.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. Cucinotta D., Vanelli M. WHO declares COVID-19 a pandemic. Acta Bio Medica Atenei Parm. 2020;91:157. - PMC - PubMed
    1. WHO Coronavirus (COVID-19) Dashboard with Vaccination Data. 2021. [(accessed on 16 June 2023)]. Available online: https://covid19.who.int/
    1. Huang C., Wang Y., Li X., Lili R., Jianping Z., Yi H., Li Z., Guohui F., Jiuyang X., Xiaoying G. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497–506. doi: 10.1016/S0140-6736(20)30183-5. - DOI - PMC - PubMed
    1. Gurol-Urganci I., Jardine J.E., Carroll F., Draycott T., Dunn G., Fremeaux A., Harris T., Hawdon J., Morris E., Muller P. Maternal and perinatal outcomes of pregnant women with SARS-CoV-2 infection at the time of birth in England: National cohort study. Am. J. Obstet. Gynecol. 2021;225:522-e1. doi: 10.1016/j.ajog.2021.05.016. - DOI - PMC - PubMed
    1. WAPM (World Association of Perinatal Medicine) Working Group on COVID-19. Saccone G., Sen C., Di Mascio D., Galindo A., Grünebaum A., Yoshimatsu J., Stanojevic M., Kurjak A., Chervenak F., et al. Maternal and perinatal outcomes of pregnant women with SARS-CoV-2 in-fection. Ultrasound Obstet. Gynecol. 2021;57:232–241. - PubMed

Publication types